Cargando…
Changes in Clinical Manifestations and Course of Systemic Lupus Erythematosus and Secondary Antiphospholipid Syndrome over Three Decades
Systemic lupus erythematosus (SLE) is often associated with antiphospholipid syndrome (APS), which potentially results in a more severe disease course and reduced life expectancy. Since the therapeutic guidelines have been refined in the last 15 years, we assumed that the diseases course has become...
Autores principales: | Nagy, Nikolett, Papp, Gábor, Gáspár-Kiss, Eszter, Diószegi, Ágnes, Tarr, Tünde |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10136176/ https://www.ncbi.nlm.nih.gov/pubmed/37189836 http://dx.doi.org/10.3390/biomedicines11041218 |
Ejemplares similares
-
Role of Altered Metabolism of Triglyceride-Rich Lipoprotein Particles in the Development of Vascular Dysfunction in Systemic Lupus Erythematosus
por: Diószegi, Ágnes, et al.
Publicado: (2023) -
Altered Circulating Follicular T Helper Cell Subsets and Follicular T Regulatory Cells Are Indicators of a Derailed B Cell Response in Lupus, Which Could Be Modified by Targeting IL-21R
por: Szabó, Krisztina, et al.
Publicado: (2022) -
Pulmonary manifestations of systemic lupus erythematosus patients with and without antiphospholipid syndrome
por: Hamdani, Muhammad Afzal, et al.
Publicado: (2015) -
Association of Antiphospholipid Antibodies with Clinical Manifestations in Children with Systemic Lupus Erythematosus
por: Petrovic, Gordana, et al.
Publicado: (2023) -
Childhood-Onset Systemic Lupus Erythematosus Presenting With Concomitant Gastrointestinal Manifestation and Antiphospholipid Syndrome
por: Mohd Shukri, Nur Diyana, et al.
Publicado: (2023)